300 likes | 412 Views
Innovation Acceleration Partner Fellows Program Approaches to Improving Commercialization and Innovation National Science Foundation Partner for Innovation Award ID: 0650294 W ashington University in St. Louis and the University of Missouri-Columbia Presented to:
E N D
Innovation Acceleration Partner Fellows Program Approaches to Improving Commercialization and Innovation National Science Foundation Partner for Innovation Award ID: 0650294 Washington University in St. Louis and the University of Missouri-Columbia Presented to: Tiger/Kauffman Sponsored Workshop February 27, 2010 Ken Harrington Washington University in St. Louis
Overview • Grant goals • Approach • First year outcomes • Issues for year two • Valley of Death
Grant Goals • Train fellows • Reduce roadblocks that discourage faculty • Find new innovation models • Move science from bench to the market • Enhance the culture
Targeted Roadblocks • Lack of time • Limited understanding of the commercialization process • Lack collaborative social network • Fear of publication delays
Approach • Focus on researchers • Work within the existing framework • Provide new support to researcher • Discuss possibilities openly • Consider “breakthrough” approaches
IAP Fellows • Amit Kumar • Ph.D. Molecular Biophysics • Justin Brown • Ph.D. Pharmacology • Kunal Rehani • Ph.D. Immunology
Overview of Wash U Technologies • Triage I Criteria: • Technology • Licensing or start-up • Stage of development • Intellectual Property (IP) • Triage II Criteria: • Triage I Criteria AND… • OTM approval • Inventor enthusiasm • Market analysis • FDA regulatory process
Majority OTM Supplied 75 Opportunities
BioDesign Fellows • Rebecca Rone • MS BioEngineering • Anthony Harris • MD/MBA • Jonathan Thompson Jr. • MD
Three Phases of Biodesign MD • Phase One (Physician) Clinical Emersion • Phase Two (Engineer) Product design • Phase Three (MBA) Business Development Critical Mass ENG MBA
Program Detail – Applied Research Needs & Solutions Product Business Plan
First Year • 15 Invention Disclosures 1/8 of all FY09 Columbia campus disclosures • 2 Provisional Patents Filed • Prototype animal testing • Founding of Limited Liability Company SBIR application submitted Missouri LSRB commercialization letter of intent
MU Invention Disclosures • 9 Minimally Invasive Devices • 3 Real Time Patient Monitoring Devices • 2 Minimally Invasive Cosmetic Devices • 1 Laparoscopic Trainer
. Fellows’ Impact Entrepreneurial self-efficacy Perceived need for new outcome Have idea for start-up Entrepreneurial expectancy Entrepreneurial desirability What Environmental Factors are the Multipliers Creating Entrepreneurial Intent? Entrepreneurial intent
Year 2 Issues Logic Environment Fellows’ skills Duration of fellowship Fellow funding ($60K@) Proof of concept and prototype funding ($TBD) Patent funding Transaction costs & time • # quality opportunities • # undisclosed opportunities • # concurrent projects • Triage • Types of technology • Start-up
Valley of Death Regulatory Process Rapid Prototyping Value Milestone Rapid Prototyping Proof of Concept Funding Faster Resource Access Lower Transaction Cost Faster Decisions Entrepreneurial Partner Invention Disclosure
Key Questions? • Process improvement? • Structural change? • Amount of resources? • Sustainability? • Level of breakthrough
Contact Information Ken Harrington, Managing Director Skandalaris Center for Entrepreneurial StudiesWashington University in St. Louis Campus Box 1133One Brookings DriveSt. Louis, Missouri 63130314-935-9134harrington@wustl.eduhttp://www.sces.wustl.edu/http://www.ideabounce.com/